GoldStone Asia Pharm Overview

  • Year Founded
  • 1991

Year Founded

  • Status
  • Public

  • Employees
  • 1,794

Employees

  • Stock Symbol
  • 300434

Stock Symbol

  • Investments
  • 4

  • Share Price
  • $1.62
  • (As of Wednesday Closing)

GoldStone Asia Pharm General Information

Description

Sichuan Goldstone Asia Pharmaceutical Inc is engaged in development and application of steel-reinforced plastic composite pipe technology, providing customers with steel-reinforced plastic composite pipes from pipe structure, production process to construction technology. The company is also engaged in research and development, production and sales of medicines and health products.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • Floor 8, Area A1, Dadi Xinguanghua Plaza
  • No. 8 Jiayuan Road, Qingyang District
  • Chengdu, Sichuan 610200
  • China
+86 028
Primary Industry
Pharmaceuticals
Stock Exchange
SHE
Corporate Office
  • Floor 8, Area A1, Dadi Xinguanghua Plaza
  • No. 8 Jiayuan Road, Qingyang District
  • Chengdu, Sichuan 610200
  • China
+86 028

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GoldStone Asia Pharm Stock Performance

As of 18-Nov-2026, GoldStone Asia Pharm’s stock price is $1.62. Its current market cap is $651M with 402M shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.62 $1.67 $1.27 - $2.15 $651M 402M 29M $0.06

GoldStone Asia Pharm Financials Summary

As of 30-Sep-2026, GoldStone Asia Pharm has a trailing 12-month revenue of $151M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 721,754 554,574 388,104 531,566
Revenue 150,956 144,395 153,628 170,914
EBITDA 29,256 35,355 31,102 36,751
Net Income 25,600 18,303 12,788 17,838
Total Assets 476,240 460,961 418,467 437,525
Total Debt 15,831 10,862 10,665 16,199
Public Fundamental Data provided by Morningstar, Inc. disclaimer

GoldStone Asia Pharm Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GoldStone Asia Pharm‘s full profile, request access.

Request a free trial

GoldStone Asia Pharm Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GoldStone Asia Pharm Investments & Acquisitions (4)

GoldStone Asia Pharm’s most recent deal was a Later Stage VC with Solipharma for . The deal was made on 28-Aug-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Solipharma 28-Aug-2019 Later Stage VC Drug Discovery
GoldStone Asia Pharm 16-Aug-2017 Merger/Acquisition Pharmaceuticals
Hainan Asia Pharmaceutical Group 01-Aug-2017 Merger/Acquisition Pharmaceuticals
GoldStone Asia Pharm 05-Aug-1991 Joint Venture Pharmaceuticals
To view GoldStone Asia Pharm’s complete investments and acquisitions history, request access »

GoldStone Asia Pharm ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Machinery

Industry

Rank

Percentile

Industrial Machinery

Subindustry

Rank

Percentile

To view GoldStone Asia Pharm’s complete esg history, request access »

GoldStone Asia Pharm FAQs

  • When was GoldStone Asia Pharm founded?

    GoldStone Asia Pharm was founded in 1991.

  • Where is GoldStone Asia Pharm headquartered?

    GoldStone Asia Pharm is headquartered in Chengdu, China.

  • What is the size of GoldStone Asia Pharm?

    GoldStone Asia Pharm has 1,794 total employees.

  • What industry is GoldStone Asia Pharm in?

    GoldStone Asia Pharm’s primary industry is Pharmaceuticals.

  • Is GoldStone Asia Pharm a private or public company?

    GoldStone Asia Pharm is a Public company.

  • What is GoldStone Asia Pharm’s stock symbol?

    The ticker symbol for GoldStone Asia Pharm is 300434.

  • What is the current stock price of GoldStone Asia Pharm?

    As of 18-Nov-2026 the stock price of GoldStone Asia Pharm is $1.62.

  • What is the current market cap of GoldStone Asia Pharm?

    The current market capitalization of GoldStone Asia Pharm is $651M.

  • What is GoldStone Asia Pharm’s current revenue?

    The trailing twelve month revenue for GoldStone Asia Pharm is $151M.

  • What is GoldStone Asia Pharm’s annual earnings per share (EPS)?

    GoldStone Asia Pharm’s EPS for 12 months was $0.06.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process